Genetic Design and Manufacturing Corporation

GDMC secures $28.1m capital from Series A funding 

Celadon Partners led the founding round.

SG-based biotech firm Genetic Design and Manufacturing Corporation (GDMC) secured $28.1m (US$21m) from a Series A funding round led by Celadon Partners.

WI Harper Group, SEEDS Capital, and NSG Ventures also participated in the funding round.

GDMC said it plans to use the funds to promote novel technology and process efficiency improvements to drive greater manufacturing cost reductions for partners aiming to advance medicines through clinical trials and towards commercialisation.

The biotech firm is currently constructing a 155,000 sq ft pre-clinical, clinical, and commercial facility supporting Cell, Gene, and Nucleic Acid Therapies (CGNT).

GDMC has already signed their first clients and is taking reservations for the clinical and commercial facilities expected to open in a staggered format from 2024 to 2027.

Follow the links for more news on

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!